Roles of iron in neoplasia
Author:
- 1 August 1992
- journal article
- review article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 34 (2) , 123-140
Abstract
Research and clinical observations during the past six decades have shown that: Iron promotes cancer cell growth; Hosts attempt to withhold or withdraw iron from cancer cells; and Iron is a factor in prevention and in therapy of neoplastic disease. Although normal and neoplastic cells have similar qualitative requirements for iron, the neoplastic cells have more flexibility in acquisition of the metal. Excessive iron levels in animals and humans are associated with enhanced neoplastic cell growth. In invaded hosts, cytokine-activated macrophages increase intracellular ferritin retention of the metal, scavenge iron in areas of tumor growth, and secrete reactive nitrogen intermediates to effect efflux of nonheme iron from tumor cells. Procedures associated with lowering host intake of excess iron can assist in prevention and in management of neoplastic disease. Chemical methods for prevention of iron assimilation by neoplastic cells are being, developed in experimental and clinical protocols. The antineoplastic activity of a considerable variety of chemicals, as well as of radiation, is modulated by iron. The present article focuses on recent findings and suggests directions for further canceriron research.Keywords
This publication has 103 references indexed in Scilit:
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- Body Iron Stores and the Risk of CancerNew England Journal of Medicine, 1988
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Prevalence of Hemochromatosis among 11,065 Presumably Healthy Blood DonorsNew England Journal of Medicine, 1988
- Further Evidence Supporting a Cause and Effect Relationship Between Blood Transfusion and Earlier Cancer RecurrenceAnnals of Surgery, 1988
- Elevated Serum Iron Levels following Administration of CisplatinumOncology, 1988
- The effect of the hypoferremic response on iron acquisition by and growth of murine lymphoma cellsBiochemistry and Cell Biology, 1987
- Trace elements and the liverJournal of Hepatology, 1987
- Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary HemochromatosisNew England Journal of Medicine, 1985
- Iron depletion: Possible cause of tumor cell cytotoxicity induced by activated macrophagesBiochemical and Biophysical Research Communications, 1984